Financhill
Back

Recursion Pharmaceuticals, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Recursion Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.41 Buy
20-day SMA: 4.4 Buy
50-day SMA: 5.13 Sell
200-day SMA: 5.42 Sell
8-day EMA: 4.43 Buy
20-day EMA: 4.5 Buy
50-day EMA: 4.06 Buy
200-day EMA: 1.84 Buy

Recursion Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 49.95 Sell
Chaikin Money Flow: 18656320 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.1 - 5.14) Buy
Bollinger Bands (100): (4.53 - 5.89) Sell

Recursion Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Recursion Pharmaceuticals, Inc. Stock

Is Recursion Pharmaceuticals, Inc. Stock a Buy?

RXRX Technical Analysis vs Fundamental Analysis

Sell
40
Recursion Pharmaceuticals, Inc. (RXRX) is a Sell

Is Recursion Pharmaceuticals, Inc. a Buy or a Sell?

Recursion Pharmaceuticals, Inc. Stock Info

Market Cap:
2.4B
Price in USD:
4.66
Share Volume:
19.8M

Recursion Pharmaceuticals, Inc. 52-Week Range

52-Week High:
12.36
52-Week Low:
3.79
Sell
40
Recursion Pharmaceuticals, Inc. (RXRX) is a Sell

Recursion Pharmaceuticals, Inc. Share Price Forecast

Is Recursion Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Recursion Pharmaceuticals, Inc.

Is Recursion Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.36 per share.

Technical Analysis of Recursion Pharmaceuticals, Inc.

Should I short Recursion Pharmaceuticals, Inc. stock?

* Recursion Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.